13F filing recap · Q3 2017
What did Viking Global Investors buy in Q3 2017?
Reported stock-position changes between this filing and the previous one.
Stock value
$15.44B
Positions
59
Estimated turnover
80.0%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
New positions
TDToronto Dominion Bank$542.80Mreported value+9.64M sharesUTXRtx Corporation$485.08Mreported value+4.18M sharesADSKAutodesk, Inc.$272.72Mreported value+2.43M sharesPEParsley Energy Inc$208.06Mreported value+7.90M sharesBUDAnheuser-Busch Inbev Sa/nv$187.20Mreported value+1.57M sharesBACBank of America Corp$185.85Mreported value+7.33M sharesVZVerizon Communications Inc$183.66Mreported value+3.71M sharesEQTEqt Corporation$162.26Mreported value+2.49M sharesNWLNewell Brands Inc.$114.44Mreported value+2.68M sharesALGNAlign Technology, Inc.$108.40Mreported value+582.0K sharesLNCLincoln National Corp$73.16Mreported value+995.6K sharesALBAlbemarle Corporation$73.08Mreported value+536.1K sharesDPZDomino’s Pizza, Inc.$71.24Mreported value+358.8K sharesEFXEquifax Inc$57.00Mreported value+537.8K sharesDCPHDeciphera Pharmaceuticals Inc$47.31Mreported value+2.49M sharesJCIJohnson Controls International Plc$40.44Mreported value+1.00M sharesABEOAbeona Therapeutics Inc.$38.17Mreported value+2.24M sharesMHKMohawk Industries, Inc.$37.37Mreported value+151.0K sharesONCESpark Therapeutics Inc$21.68Mreported value+243.1K sharesCBChubb Limited$9.01Mreported value+63.2K sharesLIFEAtyr Pharma, Inc.$8.98Mreported value+1.78M shares